Q--NGS services to support clinical research

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, has issued a combined synopsis/solicitation (number 75N98026Q00369) seeking proposals for next-generation sequencing (NGS) services to support clinical research. This acquisition is conducted under FAR Subpart 12.6 and FAR 12.603 for commercial items, with an emphasis on streamlined solicitation processes. The contract will be awarded as a firm-fixed-price purchase order on a full and open competitive basis, but it is set aside exclusively for small business concerns under the North American Industry Classification System (NAICS) code 621511, which corresponds to Medical Laboratories, and the small business size standard is $41.5 million. The solicitation incorporates clauses effective as of March 13, 2026. Proposals must be submitted by May 29, 2026, and this is the only solicitation being issued—no separate written solicitation will follow. The contract aims to procure specialized NGS services to enable clinical research support activities for NIH, part of the Department of Health and Human Services. The place of performance is not specified in the notice, but the administering office is located in Bethesda, Maryland. Points of contact for the solicitation are provided for further inquiries. This acquisition is planned to remain under the simplified acquisition threshold, streamlining procurement and emphasizing best value for the Government with a focus on participation from small businesses.